Starna announce accreditation to the new Reference Material Producer (RMP) ISO 17034 Accreditation for its Certified Reference Materials (CRMs) for Photometry IPV.
Starna is perfectly placed to support laboratories accredited to the new ISO/IEC 17025:2017, where for the first time there are clear and unambiguous statements in the standard that ‘Certified values of certified reference materials from RMPs conforming to ISO 17034 provide metrological traceability’, and ‘RMPs fulfilling the requirements of ISO 17034 are considered to be competent’.
The new ISO 17034 outlines the general requirements for the producers of Reference Materials, including CRMs and is therefore an essential consideration when selecting an appropriate Reference Material Producers (RMPs) to supply your CRMs.
Starna Scientific Ltd. was the first laboratory to be accredited to ISO Guide 34 by UKAS, No. ‘4001’ in 2006. We are now pleased to announce that we have been successfully assessed according to the requirements of the recently published ISO 17034:2016 Standard.
CRMs from Starna cover the spectrum from the Deep UV to the Mid IR for wavelength accuracy, absorbance/photometric linearity, stray light and instrument resolution. They also offer a wide selection of fluorescent references, and other formats such as plate readers and point of care devices are covered.
Starna – Supporting your data integrity through fully compliant Instrument Performance Qualification CRMs
Company name: Starna Scientific Ltd.
Website: www.starna.com
E-mail: sales@starna.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.